Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease

被引:124
|
作者
Wong, BWC [1 ]
Wong, D [1 ]
McManus, BM [1 ]
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Pathol & Lab Med, ICAPTURE Ctr,McDonald Res Labs, Vancouver, BC V6Z 1Y6, Canada
基金
加拿大健康研究院;
关键词
fractalkine; CX3CR1; atherosclerosis; diabetes mellitus; transplant vascular disease; chemokines;
D O I
10.1016/S1054-8807(02)00111-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fractalkine is a novel chemokine that mediates both firm adhesion of leukocytes to the endothelium via CX3CR1 and leukocyte transmigration out of the bloodstream. Fractalkine has recently been shown to play a role in the pathogenesis of acute organ rejection. Since its expression is regulated by inflammatory agents such as LPS, IL-1, and TNF-alpha, fractalkine involvement in atherosclerosis and transplant vascular disease (TVD) is of particular interest. In this study, we characterized the presence of fractalkine and its receptor CX3CR1 in human coronary arteries from normal, atherosclerotic, diabetic, and TVD settings. Method: Polyclonal rabbit antibodies were used to immunostain human fractalkine and CX3CR1 to localize their presence in transverse sections of the proximal left anterior descending and/or right coronary arteries. Slides were scored in a blinded fashion for intensity of staining (0 to 4+) and for localization in vessel walls. Results: Normal coronary arteries showed no fractalkine staining. In atherosclerotic coronary arteries, staining was localized to the intima, media, and adventitia. Within the media, fractalkine expression was seen in macrophages, foam cells, and smooth muscle cells (SMCs). Diabetic vessels showed similar staining patterns to atherosclerotic coronaries, with much stronger staining in the deep intima. Transplanted coronaries showed staining in the endothelium, intima, and adventitia in early disease, and intimal, medial, and adventitial staining in late disease. CX3CR1 staining was seen in the coronary arteries of all cases, with specific localization to regions with fractalkine staining. Conclusion: The distinctive staining patterns in native atherosclerosis, diabetes mellitus with atherosclerosis, and TVD indicate that the expression of fractalkine and CX3CR1 may be important in the pathogenesis of these diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:332 / 338
页数:7
相关论文
共 50 条
  • [1] Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease
    Loh, Shu Xian
    Ekinci, Yasemin
    Spray, Luke
    Jeyalan, Visvesh
    Olin, Thomas
    Richardson, Gavin
    Austin, David
    Alkhalil, Mohammad
    Spyridopoulos, Ioakim
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [2] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [3] Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease
    Patel, A.
    Jagadesham, V. P.
    Porter, K. E.
    Scott, D. J. A.
    Carding, S. R.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (01) : 20 - 27
  • [4] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Apostolakis, Stavros
    Spandidos, Demetrios
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (10) : 1251 - 1256
  • [5] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186
  • [6] Role of fractalkine/CX3CL1 and its receptor CX3CR1 in allergic diseases
    Julia, Valerie
    Staumont-Salle, Delphine
    Dombrowicz, David
    M S-MEDECINE SCIENCES, 2016, 32 (03): : 260 - 266
  • [7] Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
    Hasegawa, M
    Sato, S
    Echigo, T
    Hamaguchi, Y
    Yasui, M
    Takehara, K
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 21 - 28
  • [8] Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
    Gazerani, P.
    Cairns, B. E.
    Dong, X. D.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [10] Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
    Hosokawa, Y
    Nakanishi, T
    Yamaguchi, D
    Nakae, H
    Matsuo, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 506 - 512